Does EMPAGLIFLOZIN Cause Coronary artery bypass? 52 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Coronary artery bypass have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.1% of all adverse event reports for EMPAGLIFLOZIN.
52
Reports of Coronary artery bypass with EMPAGLIFLOZIN
0.1%
of all EMPAGLIFLOZIN reports
4
Deaths
34
Hospitalizations
How Dangerous Is Coronary artery bypass From EMPAGLIFLOZIN?
Of the 52 reports, 4 (7.7%) resulted in death, 34 (65.4%) required hospitalization, and 6 (11.5%) were considered life-threatening.
Is Coronary artery bypass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 52 reports have been filed with the FAERS database.
What Other Side Effects Does EMPAGLIFLOZIN Cause?
Diabetic ketoacidosis (3,644)
Fungal infection (1,941)
Blood glucose increased (1,797)
Euglycaemic diabetic ketoacidosis (1,769)
Weight decreased (1,661)
Urinary tract infection (1,439)
Ketoacidosis (1,411)
Dizziness (1,372)
Nausea (1,333)
Vomiting (1,201)
What Other Drugs Cause Coronary artery bypass?
ROSIGLITAZONE (1,181)
METFORMIN\ROSIGLITAZONE (181)
ADALIMUMAB (162)
EVOLOCUMAB (147)
AVANDIA (111)
RANOLAZINE (100)
RISANKIZUMAB-RZAA (93)
ETANERCEPT (76)
FLUTICASONE\SALMETEROL (75)
ASPIRIN (64)
Which EMPAGLIFLOZIN Alternatives Have Lower Coronary artery bypass Risk?
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN
EMPAGLIFLOZIN vs EMSAM
EMPAGLIFLOZIN vs EMTRICITABINE